Background-Inhomogeneity of dose distribution and anatomic aspects of the atherosclerotic plaque may influence the outcome of irradiated lesions after balloon angioplasty (BA). We evaluated the influence of delivered dose and morphological characteristics of coronary stenoses treated with ␤-radiation after BA. Methods and Results-Eighteen consecutive patients treated according to the Beta Energy Restenosis Trial 1.5 were included in the study. The site of angioplasty was irradiated with the use of a ␤-emitting 90 Sr/ 90 Y source. With the side branches used as anatomic landmarks, the irradiated area was identified and volumetric assessment was performed by 3D intracoronary ultrasound imaging after treatment and at 6 months. The type of tissue, the presence of dissection, and the vessel volumes were assessed every 2 mm within the irradiated area. The minimal dose absorbed by 90% of the adventitial volume (D v90 Adv) was calculated in each 2-mm segment. Diffuse calcified subsegments and those containing side branches were excluded. Two hundred six coronary subsegments were studied. Of those, 55 were defined as soft, 129 as hard, and 22 as normal/intimal thickening. Plaque volume showed less increase in hard segments as compared with soft and normal/intimal thickening segments (PϽ0.0001). D v90 Adv was associated with plaque volume at follow-up after a polynomial equation with linear and nonlinear components (rϭ0.71; Pϭ0.0001). The multivariate regression analysis identified the independent predictors of the plaque volume at follow-up: plaque volume after treatment, D v90 Adv, and type of plaque. Conclusions-Residual plaque burden, delivered dose, and tissue composition play a fundamental role in the volumetric outcome at 6-month follow-up after ␤-radiation therapy and
ndovascular radiation therapy is a promising new technique aimed at preventing restenosis after percutaneous coronary intervention. [1] [2] [3] Although its effectiveness has been proven in the treatment of in-stent restenosis, 4 the value of intracoronary irradiation in de novo coronary lesions remains to be established. Radiation delivered to the coronary artery by means of catheter-based systems can use both ␥-and ␤-emitters. 5 Long-term results after treatment may be influenced by absolute dose and by the homogeneity in dose distribution. ␤-Emitters demonstrate a more rapid dose falloff than ␥-emitters because of the short range of electrons. 6 This feature may lead to a less homogeneous dose distribution when treating coronary segments with variable degrees of curvature, tapering, remodeling, and plaque extent. The use of dose-volume histograms allows one to evaluate the cumulative dose received by a certain specified tissue volume 7 and has been recently implemented in the field of intracoronary brachytherapy as a tool for dosimetry. 8 Aims of the study were (1) to determine, by the use of dose-volume histograms, the dose distribution of the ␤-emitter 90 Sr/ 90 Y along the coronary irradiated segment when delivered by a noncentered device, (2) to establish the dose that could be predictive of efficacy in intracoronary brachytherapy, and (3) to determine the intravascular ultrasound (IVUS) predictors of the plaque volume at 6-month follow-up of coronary segments treated with balloon angioplasty (BA) followed by ␤-radiation therapy.
Methods

Patient Selection
Eighteen consecutive patients with single de novo coronary stenosis successfully treated with BA followed by intracoronary ␤-radiation therapy were included in the study. Patients receiving a stent were excluded from the analysis. ␤-Radiation was delivered according to the Beta Energy Restenosis Trial 1.5. The isotope selected was the pure ␤-emitting Y, and patients were randomly assigned to receive 12, 14, or 16 Gy at 2 mm from the source axis. The inclusion and exclusion criteria of this trial have been previously reported. 9 The delivery of the radiation was performed by the use of the Beta-Cath System (Novoste Corp). 10 The radiation source train of this system consists of a series of 12 independent 2.5-mm-long cylindrical seeds that contain the 90 Sr/ 90 Y sources and is bordered by 2 gold radiopaque markers at distal and proximal parts separated by 30 mm. 10 
IVUS Analysis
The treated coronary segment was evaluated by means of 3D IVUS imaging, which allowed volumetric calculations of the irradiated area. The selection of the area of interest has been reported elsewhere. 11 In brief, a few steps were followed: First, an angiogram was performed after positioning the delivery catheter and the relation between anatomic landmarks and the 2 gold markers were documented. The anatomic landmark closest to either of the gold markers was used as a reference point. This angiographic reference point was identified during a contrast injection with the IVUS imaging element at the same position as the gold marker of the source. The image from the IVUS imaging element was recorded and the reference point identified. During the subsequent pullback, this reference point was recognized and used for selecting the area subject to the analysis: 30 mm for the irradiated segment. 12 The system used for imaging was a mechanical IVUS system (ClearView, CVIS, Boston Scientific Corp) with a sheath-based IVUS catheter incorporating a 30-MHz, single-element transducer rotating at 1800 rpm (Ultracross, CVIS). The transducer is placed inside a 2.9F, 15-cm-long sonolucent distal sheath that alternatively houses the guide wire (during the catheter introduction) or the transducer (during imaging). The IVUS transducer was withdrawn through the stationary imaging sheath by an ECG-triggered pullback device with a stepping motor. 12 The ECG-gated image acquisition and digitization was performed by a workstation designed for the 3D reconstruction of echocardiographic images 12 (EchoScan, Tomtec). Description of this system has been previously reported in detail. [12] [13] [14] In brief, the steering logic of the workstation considered the heart rate variability and only acquired images from cycles meeting a predetermined range and coinciding with the peak of the R wave. If an R-R interval failed to meet the preset range, the IVUS catheter remained at the same site until a cardiac cycle met the predetermined R-R range. The IVUS transducer then was withdrawn 0.2 mm to acquire the next image. [12] [13] [14] This system ensures the segment-to-segment independence by avoiding taking images during the axial movement of the IVUS catheter that occurs during the cardiac cycle. Given the slice thickness of 0.2 mm and the length subject to the analysis of 30 mm (distance between the 2 gold markers of the radiation source), 150 crosssectional images per segment were digitized and analyzed. A semiautomatic contour detection program was used for the 3D analysis. 15 This program constructs 2 longitudinal sections from the data set and identifies the contours corresponding to the lumenintima and media-adventitia boundaries. Corrections could be performed interactively by "forcing" the contour through visually identified points; the entire data set then was updated. 15 Careful checking and editing of the contours of the 150 planar images was performed with an average of 45 minutes for complete evaluation. The area encompassed by the lumen-intima and media-adventitia boundaries defined the luminal and the total vessel volumes, respectively. The difference between total vessel and luminal volumes defined the plaque volume. Because media thickness cannot be measured accurately, we assumed that the plaque volume included the atherosclerotic plaque and the media. 16 Volumetric data were calculated by the formula Vϭ⌺ n iϭ1 A i ⅐ H, where Vϭvolume, Aϭarea of total vessel or lumen or plaque in a given cross-sectional ultrasound image, Hϭthickness of the coronary artery slice that is reported by this digitized cross-sectional IVUS image, and nϭthe number of digitized cross-sectional images encompassing the volume to be measured. 15 At follow-up, meticulous matching of the region of interest was performed by comparing the longitudinal reconstruction with that after treatment as previously described 11 ( Figure 1 ). The feasibility and intraobserver and interobserver variability of this system have been previously reported. 11, 13, 17, 18 For the purposes of the study, the computed volume of the irradiated segment was divided into 2-mm-long subsegments. Since the irradiated segment measured 30 mm, 15 subsegments were defined per patient, each of them with 10 IVUS cross sections (0.2 mm per cross section). All individual cross sections were studied by 2 investigators, blinded to the dosimetry results. Type of plaque and the 
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presence of dissection were qualitatively assessed. Type of plaque was defined in every cross section as intimal thickening, soft, fibrous, mixed, and diffuse calcified according to the guidelines previously reported. 19 Intimal thickening was defined when the thickness of the intima-media complex was Ͻ0.3 mm. 19 Soft tissue was defined when Ն80% of the cross-sectional area was constituted by material showing less echoreflectivity than the adventitia, with an arc of calcium Ͻ10°, fibrous plaque when the echoreflectivity of Ն80% of the material was as bright as or brighter than the adventitia without acoustic shadowing, diffuse calcified plaque when it contained material brighter than the adventitia showing acoustic shadowing in Ͼ90°, and mixed when the plaque did not match the 80% criterion. 19 We categorized the 2-mm-long subsegments as normal/ intimal thickening, soft, hard (fibrous and mixed), and diffuse calcified when Ն80% of the cross sections within the subsegment were of the same type. In those cross sections containing up to 90°o f calcium arc, the contour of the external elastic membrane was imputed from noncalcified slices. Dissection of the vessel was defined as a tear parallel to the vessel wall. 19 Changes in luminal, plaque, and total vessel volume between immediately after treatment and at follow-up were also computed per subsegment. Those subsegments in which the origin of side branches involved Ͼ90°of the circumferential arc in Ͼ50% of the cross sections or were defined as diffuse calcified were excluded from the analysis.
Dose Calculation
The actual dose received by the vessel was retrospectively calculated by means of dose-volume histograms 7 in every 2-mm-long subsegment. This method is based on quantitative IVUS under the assumption that the radiation source is positioned at the same place as the IVUS catheter. 8 The distance between the center of the catheter and media-adventitia interface was calculated in 24 pie slices (15°) in all cross sections corresponding to the irradiated area. 9 Considering the prescribed dose and the accurate geometric data obtained from the IVUS, the cumulative curve of the dose-volume histogram for a predefined volume (ie, adventitia as calculated at 0.5 mm outside the external elastic membrane) can be obtained (Figure 2) . From this curve, the minimum dose received by 90% of the adventitial volume (D v90 Adv) was calculated. The methodology and feasibility of this dosimetry approach in vascular brachytherapy has been previously reported. 8 
Statistical Analysis
Data are presented as meanϮSD or proportions. Differences in quantitative IVUS data between the types of tissue were assessed by means of 1-way ANOVA. Differences in quantitative IVUS data between subsegments with and without dissection and with and without calcium were evaluated by the use of an unpaired Student's t test. To determine the relation between the dose received by the adventitia and the plaque volume at follow-up, linear regression analysis was performed first. Then, nonlinear components were added to the equation (x Ϫ1 and x Ϫ2 were added to describe the steep increase of plaque volume at low dose). These components were included in the model if they described the relation significantly better. Finally, the model was corrected for the plaque volume after treatment. Multivariable regression analyses were performed to identify independent predictors of plaque volume at follow-up among IVUS-derived (types of tissue, dissection, and plaque volume after treatment) and dosimetric variables (D v90 Adv). All tests were 2-tailed, and a value of PϽ0.05 was considered statistically significant.
Results
Baseline Characteristics
Two hundred seventy subsegments were defined in 18 patients successfully treated with BA followed by intracoronary brachytherapy. Sixty-four subsegments were excluded from the final analysis because of either diffuse calcified plaque that precluded the quantification of the total vessel volume (nϭ30) or side branches that involved Ͼ90°of the circumferential arc in Ͼ50% of the cross sections (nϭ34). Therefore, 206 irradiated subsegments were the subject of the study. Fifty-five (27%) subsegments were defined as soft, 129 (62%) as hard, and 22 (11%) as normal/intimal thickening. Dissection was observed in 34 (16.5%) subsegments. (Figure 4) . The association between D v90 Adv with the plaque volume at follow-up is depicted in Figure 5 . The model appeared to follow a polynomial equation with linear and nonlinear components. Nonlinear components described the increase in plaque volume at lower doses, whereas the residual plaque volume after treatment accounted for the linear relation of the curve. Changes in plaque volume appeared to decrease with dose ( Figure 6 ). Four Gray was the minimum effective dose to be delivered to 90% of the adventitia because subsegments receiving at least this dose demonstrated a significantly smaller increase in plaque volume as compared with those receiving Ͻ4 Gy (PϽ0.001). As a result, luminal volume decreased significantly less in those subsegments receiving Ն4 Gy and even increased when the minimal dose to the adventitia was Ͼ6 Gy. Multivariable regression analyses identified plaque volume after treatment as a positive predictor of plaque volume at follow-up, whereas D v90 Adv and type of plaque (hard) were negative predictors (Table) .
Volumetric Changes and Dosimetry
Discussion
This study demonstrates for the first time the relation between plaque increase, as assessed by IVUS, and the dose received by the adventitia, as calculated by means of dose-volume histograms. A plot of dose-volume histogram is a standard method used in radiotherapy that condenses the large body of information available from conventional 3D distribution data into a plot summarizing graphically the radiation distribution throughout the target volume. 7 The assumption of the adventitia as the target tissue is supported by experimental studies. 20, 21 Scott et al 20 localized the proliferating cells in the adventitia and their migration into the neointima after angioplasty by using bromodeoxyuridine immunohistochemistry. Similarly, Waksman et al 21 demonstrated a greater cell proliferation in control vessels 3 days after angioplasty in the adventitia at the site of the medial tear as compared with the medial wall in the same region. In this study, the proliferation was significantly reduced in irradiated vessels with either a source of 90 Sr/ 90 Y or 192 Ir that delivered 14 or 28 Gy at 2 mm into the artery wall. 21 The actual dose received by the adventitia appeared to be rather low as compared with the prescribed dose at 2 mm from the source. Furthermore, the dose varied considerably between coronary subsegments, as demonstrated by the dose distribution depicted in the Figure 4 . The use of ␤-radiation may account in part for this dose inhomogeneity. As compared with ␥-radiation, ␤-sources have more fall-off because of the short range of electrons. 6 This feature may become crucial when treating vessels with a great degree of vessel tapering or, alternatively, lesions showing positive remodeling where the distance from the source to the surrounding adventitia may be smaller or greater than expected. In this regard, the use of IVUS as a tool for dosimetry in ␤-radiation therapy may become mandatory.
Dose uniformity also may be influenced by the source centering in the lumen. 22 By the use of dose-volume histograms, Carlier et al 8 demonstrated in 10 patients treated with balloon angioplasty followed by intracoronary ␤-radiation that the prescribed dose was administered in only 35% of the adventitia. After centering the source in the lumen, up to 60% of the adventitia may have received this dose.
The remnant plaque burden at the site of angioplasty becomes a powerful predictor of the outcome. This is in accordance with other studies that identified, either in nonstented or stented coronary segments, postintervention crosssectional area as a predictor of restenosis. 23, 24 In this regard, the usefulness of a debulking technique before radiation therapy should be addressed in further studies.
D v90 Adv was also identified as an independent predictor of the plaque volume at follow-up. The relation between D v90 Adv and plaque volume at follow-up appeared to be polynomial with linear and nonlinear components. This may model the survival curve of mammalian cells. 25 The minimal effective dose to be delivered to 90% of the adventitial volume appeared to be 4 Gy. Further increase in dose resulted in net increase in luminal volume at follow-up. Similarly, in a subgroup analysis of the SCRIPPS trial, late loss was significantly lower when the entire circumference of the adventitial border was exposed to Ն8 Gy. 26 Radiation doses Ͼ20 Gy have been suggested to be able to completely eliminate the smooth muscle cell population from the treated area. 27 However, because cells from normal tissue have a limited capacity to proliferate, 28 lower doses probably would be sufficient to permanently prevent restenosis.
Finally, subsegments containing hard tissue (fibrotic and calcified material up to 90°of the circumferential arc) demonstrated a trend to be a negative predictor of plaque volume at follow-up. Hard plaque on IVUS consists of a more mature tissue with low cellularity and high content of extracellular matrix. 29, 30 These features may induce either a physical barrier for migration of smooth muscle cells from the surrounding layers or a reduced capacity to proliferate when injured as compared with that of the soft tissue with a high concentration of smooth muscle cells. 29 -31 Further, it is hypothesized that tissue composition may potentially exert a different degree of shielding effect on radiation and thus become less effective. However, the degree of remodeling was similar between the different types of tissue, suggesting that the effects of attenuation of radiation induced by hard material (either containing calcium up to 90°of circumferential arc or mixed noncalcified tissue) may be negligible as compared with that of soft tissue.
Study Limitations
We assumed that the IVUS and the delivery catheters were lying in the same position in the treated coronary segment. The size of the IVUS catheter is smaller (2.9F) than the brachytherapy device (5F), which is thus to some extent more centered in the lumen. Although the catheters should be on the shortest 3D path in the lumen, coronary arteries have a complex curved geometry in space and can be partially deformed by the catheters. Thus, catheters with different rigidity may occupy different positions. The development of new systems incorporating the IVUS imaging element on the delivery catheter might resolve this drawback.
During irradiation, the position of the delivery catheter inside the lumen is not fixed and may vary along the cardiac cycle because of ventricular contractions, which may lead to some degree of inhomogeneity not assumed by data derived from the static end-diastolic IVUS images.
The behavior of diffuse calcified plaques after radiotherapy has not been evaluated because the acoustic shadowing would have impeded the reliable analysis of total vessel and plaque volumes. 19 It has not been possible to differentiate those areas that have been traumatized and irradiated from those only irradiated. Thus, no conclusions regarding the effect on radiation in irradiated but noninjured segments can be drawn. Further studies will address this problem by defining meticulously the injured and the irradiated areas either on IVUS or quantitative coronary angiography.
Finally, the dose as presented by the use of dose-volume histograms is not a direct measurement. The theoretical value obtained at the level of the adventitia is derived from the fall-off of the isotope and the geometrical data obtained from the IVUS study. The influence of the attenuation of the radiation caused by different tissue characteristics has not been taken into consideration. Future investigations should address the implementation of a dosimetry program on-line to prescribe the radiation dose in a more refined fashion.
